MentionFox
Home › Executive changes › Tharimmune, Inc.
Leadership changes · THAR · SEC Form 8-K, Item 5.02

Leadership changes at Tharimmune, Inc. (2026)

Before you join, sell to or invest in Tharimmune, Inc.

MentionFox check on Tharimmune, Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/tharimmune

Check Tharimmune, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Tharimmune, Inc.?

Who joined and who left Tharimmune, Inc. (THAR)? 1 appointment reported on 2026-02-06, each cited to the company's own filing.

Angela Dominy Radkowski was named Chief Operating Officer of Tharimmune, Inc., effective February 5, 2026. As of November 14, 2026, Tharimmune, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on February 6, 2026, naming 1 appointment (Form 8-K, February 6, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Gary Stetz and 2 others are also named on 6 other Form D filings ↓

Sell to companies like Tharimmune, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
In (appointed)1
Latest filing2026-02-06

Tharimmune, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-02-06. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Tharimmune, Inc. files it.

Also on the record for Tharimmune, Inc.

DateRecordFigureOur pageSource
October 27, 2026Stake report, Schedule 13G, by BlackRock, Inc.6% of the class5%+ stakesSource
July 8, 2026Stake report, Schedule 13G/A, by ARK Investment Management LLC4.74% of the class5%+ stakesSource
May 11, 2026Stake report, Schedule 13G/A, by Murtaza S. Akbar9.99% of the class5%+ stakesSource
April 15, 2026Form D, private offering$1.74M soldForm D pageSource
April 15, 2026Form D, private offering$1.23M soldForm D pageSource
February 6, 2026Stake report, Schedule 13G, by Broadridge Financial Solutions, Inc.9.99% of the class5%+ stakesSource
February 3, 2026Stake report, Schedule 13G, by ARK Investment Management LLC8.92% of the class5%+ stakesSource
February 2, 2026Stake report, Schedule 13G, by LCV Fund III, L.P.9.99% of the class5%+ stakesSource
January 21, 2026Stake report, Schedule 13G/A, by BlackRock, Inc.2.2% of the class5%+ stakesSource
October 17, 2025Stake report, Schedule 13G, by BlackRock, Inc.9.8% of the class5%+ stakesSource
July 7, 2025Form D, private offering$2.50M soldForm D pageSource
December 17, 2024Form D, private offering$2.02M soldForm D pageSource

Selling to them or working with them? See who runs Tharimmune, Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on Tharimmune, Inc. and the records around it.

The people at Tharimmune, Inc.

Tharimmune, Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on Tharimmune, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Tharimmune, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Tharimmune, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-02-06InChief Operating Officer2026-02-058-K, 2026-02-06

Who leads Tharimmune, Inc., as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to Tharimmune, Inc.?

New leaders reset buying decisions — get the Full Report on Tharimmune, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Tharimmune, Inc. (free up to 3)

Hiring for a seat like this?

Find people with the same kind of experience as the Chief Operating Officer at Tharimmune, Inc., with the record behind each one.

Find candidates like Chief Operating Officer at Tharimmune, Inc.

Every change, in the filing's words

Filed 2026-02-06 · 8-K

Appointed: Angela Dominy Radkowski, Chief Operating Officer, effective 2026-02-05

On February 5, 2026, the Board of Directors (the " Board ") of Tharimmune, Inc. (the " Company ") appointed Angela Dominy Radkowski, age 37, as Chief Operating Officer of the Company, effective February 5, 2026 (the " Effective Date ").

Also stated in this filing

  • Prior to her appointment, Ms. Radkowski served as Operations Strategy Lead and Chief of Staff to the Chief Operating Officer at DRW Holdings LLC from February 2022 to January 2026, advising senior leadership, coordinating cross-functional communication, and managing high-priority, enterprise-level initiatives.
  • Ms. Radkowski previously held positions within Citadel LLC's Treasury and Engineering organizations, where she was responsible for coordinating enterprise deliverables involving optimization, data engineering, and technology upgrades.
  • Ms. Radkowski holds a Bachelor of Science in Business Administration with a major in Finance from The Ohio State University, Max M. Fisher College of Business.
  • Ms. Radkowski will also be eligible to receive grants of time-based and/or performance-based equity awards, in a form and amount determined by the Board in its sole and absolute discretion, subject to Board approval, vesting conditions established by the Board (or its compensation committee) and other conditions.
  • The agreement contains customary confidentiality, non-compete, non-solicitation, and intellectual property provisions.
  • The COO Employment Agreement provides that Ms. Radkowski's employment is at will and may be terminated by either party at any time, with or without cause or notice.

Tools for this story

Each opens in a new tab, filled in for Tharimmune, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/tharimmune
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Who joined Tharimmune, Inc.? Leadership changes (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/tharimmune